Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The IKs channel, also known as the slow delayed rectifier potassium current, is a crucial cardiac potassium channel complex primarily formed by the co-assembly of KCNQ1 and KCNE1. This heteromeric complex is essential for proper cardiac repolarization and adaptation to physiological stress. Mutations in either component can cause inherited arrhythmia syndromes like Long QT Syndrome.
Modulation of potassium ion flow across cell membranes, affecting cardiac action potential duration and repolarization.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Channel Subfamily K Member S (IKs).